TherapeuticsMD, Inc. (TXMD)

2.22 +0.00% (+0.00)

Over 6M: -0.9%

2026-08-28
Style
Area Line Line with markers Steps Candles Hollow candles Bars

Candles need the day’s open, high and low. Those are being collected now — a company shows them once its history has been refreshed.

1.8 2 2.2
Mar Apr May Jun Jul Aug

Financials Quarterly

Figures
Revenue Gross Profit Operating Income Cost of Revenue Operating Cash Flow Free Cash Flow Net Income

A share count and earnings a share are not here: neither is money, so neither can share this axis. Both have their own panel on All charts.

All charts ›
Q3 '21 — Operating Cash Flow: -38.2M Q3 '21 — Free Cash Flow: -38.3M Q3 '21 — Net Income: -47.4M Q4 '21 — Operating Cash Flow: -39.6M Q4 '21 — Free Cash Flow: -39.6M Q4 '21 — Net Income: -43M Q1 '22 — Operating Cash Flow: -17.9M Q1 '22 — Free Cash Flow: -17.9M Q1 '22 — Net Income: -49M Q2 '22 — Operating Cash Flow: -27.1M Q2 '22 — Free Cash Flow: -27.1M Q2 '22 — Net Income: 112.3M Q3 '22 — Operating Cash Flow: -18.9M Q3 '22 — Free Cash Flow: -18.9M Q3 '22 — Net Income: -29M Q4 '22 — Operating Cash Flow: 73.2M Q4 '22 — Net Income: 77.7M Q1 '23 — Operating Cash Flow: -8.7M Q1 '23 — Net Income: -3.6M Q2 '23 — Operating Cash Flow: -3.4M Q2 '23 — Net Income: -2.4M Q3 '23 — Operating Cash Flow: -6M Q3 '23 — Net Income: -3.4M Q4 '23 — Operating Cash Flow: -5M Q4 '23 — Net Income: -883K Q1 '24 — Operating Cash Flow: -229K Q1 '24 — Net Income: -734K Q2 '24 — Operating Cash Flow: 1.5M Q2 '24 — Net Income: -1.1M Q3 '24 — Operating Cash Flow: -71K Q3 '24 — Net Income: -609K Q4 '24 — Operating Cash Flow: 17K Q4 '24 — Net Income: 252K Q1 '25 — Operating Cash Flow: 699K Q1 '25 — Net Income: -653K Q2 '25 — Operating Cash Flow: 381K Q2 '25 — Net Income: 551K Q3 '25 — Operating Cash Flow: 999K Q3 '25 — Net Income: 152K Q4 '25 — Operating Cash Flow: 375K Q4 '25 — Net Income: -619K Q1 '26 — Operating Cash Flow: 944K Q1 '26 — Net Income: 95K Q2 '26 — Operating Cash Flow: 779K Q2 '26 — Net Income: 155K -35M 0 35M 70M 105M 140M
Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26
Operating Cash Flow Free Cash Flow Net Income

Figures as at 2026-06-30, reported in USD. The newest fact in the filings is dated 2026-06-30, 61 days ago. Nothing on this page is advice.

How it scores

Five questions, each answered by the measures under it. Every figure is the company's own; the bar beside it is where that figure sits among the companies read here — the top fifth, the bottom fifth, or somewhere between. Not among all listed companies, and for a valuation multiple the low end is the good end.

Quality

How much of the revenue is really kept — and what did it take to earn it?

3.8
OE margin 93.0%
Oper. margin -120.9%
ROIC -17.4%
Accruals -8.8%
FCF margin 94.7%
OCF margin 94.7%
Asset turnover 0.087×
EBITDA margin -109.2%
ROA -0.58%
ROCE -12.2%
ROE -0.8%
Capex / sales —
Gross margin —
OCF / EBIT —

5 of 17 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Valuation

What does the price ask for what the company earns, owns and pays out?

0.5
Div. yield —
EV/EBIT —
EV/GP —
EV/OE —
EV/Sales —
FCF yield —
Fwd P/E —
P/B —
P/C —
P/E —
PEG —

0 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Durability

How predictable is the revenue, and how much of it is already committed?

1.0
RPO / sales —
RPO growth —
Segment HHI —

2 of 7 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Resilience

Can the balance sheet absorb a bad year?

6.5
ND/EBITDA —
Interest cover -494.1×
Debt / Eq 0.0×
Debt payback 0.0 yr
Quick ratio 1.9×
F-score 6.4 pts
Cash / Debt —
Cash runway —
Payout —

3 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Growth

Is the business getting bigger, and is it getting more profitable?

2.3
Sales/sh Y/Y +27.4%
Shares change +0.32%
Sales Q/Q -8.7%
Div. growth —
EBIT CAGR —
EBIT Y/Y —
EPS CAGR 4Y —
EPS Y/Y —
EPS next Y —

4 of 13 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

A measure absent from a block could not be computed from this company's filings. It is left out rather than scored as though it were bad, and the dimension is averaged over what remains. A score is measured against a fixed scale this model states; the bar is measured against the other companies, so the two can disagree — and where they do, that disagreement is the more interesting figure.